Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients
Clinical trial NCT04962425 · UNKNOWN
Trial details
- NCT number
- NCT04962425
- Sponsor
- Peking University Third Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-08
- Primary completion
- 2021-06-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.